These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 6355555)
1. [Phased clinical trials in cancer chemotherapy]. Yokoyama M Gan No Rinsho; 1983 Aug; 29(10):1205-16. PubMed ID: 6355555 [TBL] [Abstract][Full Text] [Related]
2. The Challenge of Developing New Therapies for Childhood Cancers. Balis FM Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032 [TBL] [Abstract][Full Text] [Related]
3. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma. ten Bokkel Huinink W; Carmichael J; Armstrong D; Gordon A; Malfetano J Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-19-S5-25. PubMed ID: 9122738 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics. Newell DR; Burtles SS; Fox BW; Jodrell DI; Connors TA Br J Cancer; 1999 Nov; 81(5):760-8. PubMed ID: 10555743 [TBL] [Abstract][Full Text] [Related]
6. Phase 0 clinical trials in oncology: a paradigm shift for early drug development? Takimoto CH Cancer Chemother Pharmacol; 2009 Mar; 63(4):703-9. PubMed ID: 18615251 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials. Thigpen T; Vance R; Puneky L; Khansur T Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816 [TBL] [Abstract][Full Text] [Related]
9. Clinical trial design in metastatic breast cancer: a commentary. Levine M Can J Oncol; 1995 Dec; 5 Suppl 1():40-2. PubMed ID: 8853523 [TBL] [Abstract][Full Text] [Related]
10. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic]. Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358 [TBL] [Abstract][Full Text] [Related]
11. [Comparative clinical trials]. Yokoyama M Gan To Kagaku Ryoho; 1984 Mar; 11(3):404-12. PubMed ID: 6703720 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic response in phase I trials of antineoplastic agents. Estey E; Hoth D; Simon R; Marsoni S; Leyland-Jones B; Wittes R Cancer Treat Rep; 1986 Sep; 70(9):1105-15. PubMed ID: 3527410 [TBL] [Abstract][Full Text] [Related]
13. Strategy for the development of novel anticancer drugs. Saijo N; Tamura T; Nishio K Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S97-101. PubMed ID: 12856152 [TBL] [Abstract][Full Text] [Related]
14. [Phase I trials--clinical studies of antineoplastic agents]. Takahashi H; Wakui A; Yokoyama M; Oikawa H; Yoshioka T; Matsuoka S Gan To Kagaku Ryoho; 1991 Jul; 18(9):1477-85. PubMed ID: 1854218 [TBL] [Abstract][Full Text] [Related]
15. Phase I trials of single agents in adult solid tumours: preclinical and clinical aspects. Dodion P; Kenis Y; Staquet M Drugs Exp Clin Res; 1986; 12(1-3):23-30. PubMed ID: 3732050 [TBL] [Abstract][Full Text] [Related]
17. [Note for evaluation of anticancer agents in man]. Marty M; Bizarri JP Therapie; 1997; 52(4):287-90. PubMed ID: 9437879 [TBL] [Abstract][Full Text] [Related]
18. Long time therapy with topotecan in patients with recurrence of ovarian carcinoma. Möbus V; Pfaff PN; Volm T; Kreienberg R; Kaubitzsch S Anticancer Res; 2001; 21(5):3551-6. PubMed ID: 11848522 [TBL] [Abstract][Full Text] [Related]
19. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983 [TBL] [Abstract][Full Text] [Related]
20. Pediatric phase I trials in oncology: an analysis of study conduct efficiency. Lee DP; Skolnik JM; Adamson PC J Clin Oncol; 2005 Nov; 23(33):8431-41. PubMed ID: 16293874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]